Darapladib inhibits atherosclerosis development in type 2 diabetes mellitus Sprague-Dawley rat model
By:
References
- American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 34 Suppl 1, S62–S69, 2011.10.2337/dc11-S062
- Aronson D, Rayfield EJ. How hyperglycemia promotes atherosclerosis: molecular mechanisms. Cardiovasc Diabetol 1, 1–10, 2002.
- Avogaro A, Albiero M, Menegazzo L, de Kreutzenberg S, Fadini GP. Endothelial dysfunction in diabetes: the role of reparatory mechanisms. Diabetes Care 34, S285–290, 2011.10.2337/dc11-s239
- Burns TA, Geor RJ, Mudge MC, McCutcheon LJ, Hinchcliffe KW, Belknap JK. Proinflammatory cytokine and chemokine gene expression profiles in subcutaneous and visceral adipose tissue depots of insulin-resistant and insulin-sensitive light breed horses. J Vet Intern Med 24, 932–939, 2010.10.1111/j.1939-1676.2010.0551.x
- Cacho J, Sevillano J, de Castro J, Herrera E, Ramos MP. Validation of simple indexes to assess insulin sensitivity during pregnancy in Wistar and Sprague Dawley rats. Am J Physiol Endocrinol Metab 295, E1269–E1276, 2008.
- Carlquist JF, Muhlestein JB, Anderson JL. Lipoprotein-associated phospholipase A2: a new biomarker for cardiovascular risk assessment and potential therapeutic target. Expert Mol Diagn 7, 511–517, 2007.10.1586/14737159.7.5.511
- Chait A, Bornfeldt KE. Diabetes and atherosclerosis: is there a role for hyperglycemia? J Lipid Res 50, S335–S339, 2009.
- Fukuchi M, Giaid A. Endothelial expression of endothelial nitric oxide synthase and endothelin-1 in human coronary artery disease: specific reference to underlying lesion. Journal of Technical Methods and Pathology 79, 659–670, 1999.
- Galkina E, Ley K. Vascular adhesion molecules in atherosclerosis. Arterioscler Thromb Vasc Biol 27, 2292–2301, 2007.10.1161/ATVBAHA.107.149179
- Heriansyah T, Wihastuti TA, Anita KW, Iskandar A, Suhendra RB, Setiabudi PA, Sishartami LW. Atherogenesis inhibition by darapladib administration in dyslipidemia model sprague-dawley rats. National Journal of Physiology, Pharmacy and Pharmacology 6, 52–58, 2015.
- Heriansyah T, Adam AA, Wihastuti TA, Rohman MS. Elaborate evaluation of serum and tissue oxidized LDL level with darapladib therapy: a feasible diagnostic marker for early atherogenesis. Asian Pacific Journal of Tropical Biomedicine 7, 134–138, 2016.
- Hu MM, Zhang J, Wang WY, Wu WY, Ma YL, Chen WH, Wang YP. The inhibition of lipoprotein-associated phospholipase A2 exerts beneficial effects against atherosclerosis in LDLR-deficient mice. Acta Pharmacol Sin 32, 1253–1258, 2011.10.1038/aps.2011.127
- International Diabetes Federation: IDF Diabetes Atlas (6nd ed.), 2013.
- Navale AM, Paranjape AN. Role of inflammation in development of diabetic complications and commonly used inflammatory markers with respect to diabetic complications. Int J Pharm Pharm Sci 5, 1–5, 2013.
- Samuel VT, Shulman GI. Mechanisms for insulin resistance: common threads and missing links. Cell 148, 852–871, 2012.
- Silva IT, Mello APQ, Damasceno NRT. Antioxidant and inflammatory aspects of lipoprotein-associated phospholipase A2 (Lp-PLA2): a review. Lipids in Health and Disease 10, 170, 2010.
- Silvana GT, Rifa’i M. Activity test of Vip Albumin against blood glucose levels and lymphocytes profiles in Balb/c mice as type 2 diabetes mellitus model. Jurnal Biotropika 3, 17–20, 2015.
- Sumagin R, Lomakina E, Sarelius IH. Leukocyte-endothelial cell interactions are linked to vascular permeability via ICAM-1-mediated signaling. Am J Physiol Heart Circ Physiol 295, H969–H977, 2008.
- Thompson PL, Nidorf SM, Eikelboom J. Targeting the unstable plaque in acute coronary syndromes. Clin Ther 35, 1099–1107, 2013.10.1016/j.clinthera.2013.07.332
- Turan B, Dhalla NS. Diabetic cardiomyopathy: biochemical and molecular mechanism. Springer, New York, 2014.
- Van Dijk JW, Venema M, van Mechelen W, Stehouwer CD, Hartgens F, van Loon LJ. Effect of moderate-intensity exercise versus activities of daily living on 24-hour blood glucose homeostasis in male patients with type 2 diabetes. Diabetes Care 36, 3448–3453, 2013.10.2337/dc12-2620
- Wang W-y, Zhang J, Wu W-y, Li J, Ma Y-l, Chen W-h, Yan H, Wang K, Xu WW, Shen JH, Wang YP. Inhibition of lipoprotein-associated phospholipase A2 ameliorates inflammation and decreases atherosclerotic plaque formation in ApoE-deficient mice. PLoS ONE 6, e23425, 2011.
- Wihastuti TA, Sargowo D, Tjokroprawiro A, Permatasari N, Widodo MA, Soeharto S. Vasa vasorum anti-angiogenesis through H2O2, HIF-1α, NF-κB, and iNOS inhibition by mangosteen pericarp ethanolic extract (garcinia mangostana linn) in hypercholesterol-diet-given rattus norvegicus wistar strain. Vasc Health Risk Manag 10, 523–531, 2014.
- Wihastuti TA, Heriansyah H, Soraya M, Wijayanti M, Firani NK, Iskandar A, Anita KW, Agustin D, Pujiana L, Sandika N, Ardyanto E, Puji A, Wiji Y, Febriato A, Nuraminudin A, Quirino F, Rachmawati S, Candra Y. Inhibition of oxidative stress in hypercholesterolemic rats by soy milk. Journal of Cardiovascular Disease Research 7, 74–82, 2016.
- Wilensky RL, Shi Y, Mohler ER 3rd, Hamamdzic D, Burgert ME, Li J, Postle A, Fenning RS, Bollinger JG, Pelchovitz DJ, Yang J, Mirabile RC, Webb CL, Zhang L, Zhang P, Gelb MH, Walker MC, Zalewski A, Macphee CH. Inhibition of lipoprotein-associated phospholipase A2 reduces complex coronary atherosclerotic plaque development. Nat Med 14, 1059–66, 2008.
Language: English
Page range: 69 - 75
Published on: Apr 30, 2018
Published by: Slovak Academy of Sciences, Mathematical Institute
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Related subjects:
© 2018 Titin Andri Wihastuti, Teuku Heriansyah, Hanifa Hanifa, Sri Andarini, Zuhrotus Sholichah, Yuni Hendrati Sulfia, Aditya Angela Adam, Jeki Refialdinata, Nurul Cholifah Lutfiana, published by Slovak Academy of Sciences, Mathematical Institute
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.